TOT BIOPHARM

About:

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.

Website: http://www.totbiopharm.com/

Top Investors: Vivo Capital, Cathay Capital, Chengwei Capital, Yuanta Financial Holdings Group, Center Ventures

Description:

TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs and therapies. Our mission is to build a leading brand name of oncology treatments trusted by patients and their families as well as medical professionals in China.

Total Funding Amount:

$108M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2009-01-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2018-08-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai